Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Gossamer Bio, Inc. Common Stock (GOSS)

Pharmaceutical Preparations

https://www.gossamerbio.com

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

3013 SCIENCE PARK
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/08/2019

Market Cap

191,207,060

Shares Outstanding

225,410,000

Weighted SO

225,409,314

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

BMEA --.--%

STOK --.--%

AKRO --.--%

FIXX --.--%

REPL --.--%

NVCT --.--%

LYRA --.--%

KRON --.--%

PASG --.--%

Beta

1.9290

Last Div

0.0000

Range

0.453-1.6

Chg

0.0207

Avg Vol

2111861

Mkt Cap

191207060

Exch

NASDAQ

Country

US

Phone

858 684 1300

DCF Diff

2.4317

DCF

-1.1817

Div Yield

0.0000

P/S

1.8631

EV Multiple

-4.8530

P/FV

2.3452

Div Yield %

0.0000

P/E

-2.3648

PEG

-0.0405

Payout

0.0000

Current Ratio

8.2085

Quick Ratio

8.2085

Cash Ratio

1.9227

DSO

12.9069

DIO

0.0000

Op Cycle

12.9069

DPO

89.3513

CCC

-76.4444

Gross Margin

0.9602

Op Margin

-0.6761

Pretax Margin

-0.7446

Net Margin

-0.7878

Eff Tax Rate

0.1471

ROA

-0.2165

ROE

-1.1733

ROCE

-0.2114

NI/EBT

1.0580

EBT/EBIT

1.1013

EBIT/Rev

-0.6761

Debt Ratio

0.5325

D/E

2.4393

LT Debt/Cap

0.7073

Total Debt/Cap

0.7092

Int Coverage

-129.2160

CF/Debt

-0.0195

Equity Multi

4.5806

Rec Turnover

28.2794

Pay Turnover

4.0850

Inv Turnover

0.0000

FA Turnover

41.2816

Asset Turnover

0.2748

OCF/Share

-0.0171

FCF/Share

-0.0170

Cash/Share

1.5670

OCF/Sales

-0.0377

FCF/OCF

0.9923

CF Coverage

-0.0195

ST Coverage

-2.1205

CapEx Coverage

-129.0667

Div&CapEx Cov

-129.0667

P/BV

2.3452

P/B

2.3452

P/S

1.8631

P/E

-2.3648

P/FCF

-49.7676

P/OCF

-49.3807

P/CF

-49.3807

PEG

-0.0405

P/S

1.8631

EV Multiple

-4.8530

P/FV

2.3452

DPS

0.0000

Latest Headlines (EST)

PennyStocks Nov 15, 12:52 5 Penny Stocks To Buy Now According To Insiders PennyStocks Nov 15, 12:52 5 Penny Stocks To Buy Now According To Insiders

Revenue Product Segmentation